Biocartis Group N.V.
BIOGF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $228 |
| - Cash | $25 | $25 | $0 | $52 |
| + Debt | $152 | $122 | $0 | $154 |
| Enterprise Value | $127 | $97 | $0 | $330 |
| Revenue | $0 | $0 | $57 | $24 |
| % Growth | -5.1% | -99.9% | 138% | – |
| Gross Profit | -$0 | -$0 | $28 | $7 |
| % Margin | -6.3% | -9.1% | 48.2% | 29.7% |
| EBITDA | -$0 | -$0 | -$44 | -$26 |
| % Margin | -52.6% | -51.4% | -76.5% | -108.9% |
| Net Income | -$0 | -$0 | -$65 | -$36 |
| % Margin | -105.5% | -117.3% | -113.7% | -148.1% |
| EPS Diluted | -0.34 | -0.58 | -0.5 | -0.62 |
| % Growth | 41.4% | -16% | 19.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$45 | -$33 |
| Capital Expenditures | -$0 | -$0 | -$2 | -$2 |
| Free Cash Flow | -$0 | -$0 | -$47 | -$35 |